How is coronary no reflow diagnosed in the cath lab?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Coronary No-Reflow in the Cath Lab

Coronary no-reflow is diagnosed in the cath lab primarily through angiographic assessment of TIMI flow grade and myocardial blush grade, with TIMI flow <3 or TIMI flow 3 with myocardial blush grade 0-1 being the definitive diagnostic criteria, along with <70% ST-segment resolution within 4 hours of the procedure. 1, 2

Primary Diagnostic Criteria

Angiographic Assessment

  • TIMI Flow Grade:

    • TIMI 0: No antegrade flow beyond occlusion point
    • TIMI 1: Contrast passes beyond obstruction but "hangs up" and fails to opacify entire coronary bed
    • TIMI 2: Slower contrast entry/clearance compared to normal vessels
    • TIMI 3: Normal antegrade flow and clearance
  • Myocardial Blush Grade (MBG):

    • Assesses tissue-level perfusion
    • No-reflow is diagnosed when MBG is 0 or 1 despite TIMI 3 flow 1, 2

Electrocardiographic Assessment

  • ST-segment resolution <70% within 4 hours of the procedure despite successful epicardial artery opening 1

Additional Diagnostic Methods in the Cath Lab

Direct Invasive Assessment

  • Coronary Flow Velocity Measurement:
    • Using Doppler guidewire
    • Rapid deceleration of diastolic flow velocity indicates no-reflow 1, 3

Timing of Diagnosis

  • No-reflow typically develops within the first 2 hours of reperfusion 4
  • Incidence ranges from 10-40% of patients undergoing reperfusion therapy for STEMI 1, 2

Clinical Significance and Implications

  • No-reflow is associated with:
    • Prolonged myocardial ischemia
    • Severe arrhythmias
    • Critical hemodynamic deterioration
    • Increased risk of clinical complications 1, 2
    • Poor prognosis for LV remodeling and function 2, 5
    • Increased mortality independent of infarct size 5

Differential Considerations

  • Differentiate persistent slow flow or no-reflow from competitive flow from remaining collateral channels 1
  • TIMI grade 2 flow after CTO-PCI is considered a successful result and should be differentiated from slow reflow with evidence of ongoing ischemia 1

Post-Cath Lab Confirmation

While not part of the initial cath lab diagnosis, these methods can confirm and quantify no-reflow:

  • Non-invasive imaging techniques:
    • Contrast echocardiography
    • Single-photon emission tomography
    • Positron emission tomography (PET)
    • Contrast-enhanced magnetic resonance imaging (MRI) 1, 3

Practical Approach to Diagnosis

  1. Assess TIMI flow grade immediately after intervention
  2. If TIMI flow is <3, diagnose as no-reflow
  3. If TIMI flow is 3, assess myocardial blush grade
  4. If MBG is 0-1 despite TIMI 3 flow, diagnose as no-reflow
  5. Monitor ST-segment resolution within 4 hours of the procedure
  6. Consider Doppler guidewire assessment for borderline cases

By following this systematic approach, coronary no-reflow can be promptly diagnosed in the cath lab, allowing for timely intervention with intracoronary vasodilators or other appropriate therapies to potentially improve outcomes 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Coronary No-Reflow Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

No-reflow: incidence and detection in the cath-lab.

Current pharmaceutical design, 2013

Research

Coronary no reflow.

Journal of molecular and cellular cardiology, 2012

Research

No-reflow phenomenon: maintaining vascular integrity.

Journal of cardiovascular pharmacology and therapeutics, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.